Prostate cancer risk: could a simple blood test predict it?

NCT ID NCT03383016

Ongoing Knowledge-focused Sponsor: CHU de Quebec-Universite Laval Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is looking at how things like diet, physical activity, and other lifestyle habits might affect a man's risk of getting prostate cancer. Researchers are studying more than 2000 men who are at higher risk to find biological markers in the blood that could help predict risk. The goal is to eventually use these markers to personalize prevention strategies, such as recommending specific diet or exercise changes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple blood test that helps identify men at high risk for prostate cancer, allowing them to make lifestyle changes to lower that risk.
What could go wrong: This is an observational study, not a treatment trial. It may not find clear biomarkers, and any findings would need further validation before being used in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPIDEMIOLOGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Inflammation prostate cancer prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EPIDEMIOLOGY PROSTATE CANCER

Contacts and locations

Locations

CHU de Quebec- Université Laval

Québec, Quebec, G1R3S1, Canada
Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Montreal, Quebec, H2X 0A9, Canada
Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Sherbrooke, Quebec, J1H 5N4, Canada
McGill University Health Center

Montreal, Quebec, H4A 3J1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.